Medicare Plus logo

Medicareplus International Ltd

Incorporated in 2007, Medicareplus International is one of the fastest growing organisations for skin protection in wound care, continence care and stoma care. With a complete commitment to ensuring that patients with chronic health conditions have the support they need to continue to enjoy the best possible quality of life, Medicareplus International have created affordable yet exceptional skin protection products that retain skin integrity and improve healing.

We passionately believe in working collaboratively with our customers, to develop, deliver and support professional education programs that are tailored to the bespoke requirements of your trust. The highly qualified and experienced team at Medicareplus International help educate healthcare professionals on safely and effectively using our products to protect the patients’ skin integrity in wound care, continence care and stoma care.

Medicareplus International, The Skin Protection Specialists In: Wound Care


Moisture-Associated Skin Damage (MASD), the result of prolonged exposure to skin from moisture, causes a varying degree of excoriation which can prove to be debilitating for individuals. Instituting a structured skin care regimen for patients with MASD is essential. S.M.A.R.T., a visual framework developed by Medicareplus International helps nurses and care staff of any level to categorise, report and treat MASD appropriately in-line with NHSi guidelines. The S.M.A.R.T. Resource has been endorsed by The National Institute for Health and Care Excellence (NICE) and is publicly available to anyone wanting to implement a structured approach to identifying, treating and reporting MASD in their workplace. 


The Total Barrier Protection™ Strategy (TBP) developed by Medicareplus International provides a moisture damage treatment strategy to balance patient needs while managing budgets by simplifying product choice. TBP includes Medi Derma-S Barrier Cream, Medi Derma-S Barrier Film and Medi Derma-PRO Skin Protectant Ointment with Foam & Spray Incontinence Cleanser in the management of Moisture-Associated Skin Damage (MASD), depending mild, moderate and severe level of damage. Lifteez Medical Adhesive Remover also supports the TBP strategy by preventing MARSI (Medical Adhesive-Related Skin Injury)

Continence Care


A structured skin care regimen in Incontinence Associated Dermatitis (IAD) is essential to protect vulnerable skin in persons with chronic and acute incontinence, and is based on avoiding contact between urine or stool and the skin and protecting the skin from the damaging effects of urinary and/or faecal incontinence. 

The TBP™ Strategy also includes Medi Derma-PRO Skin Protectant Ointment with Foam & Spray Incontinence Cleanser that provides significant benefits in the management of moderate to severe IAD.  

Stoma Care 

Skin damage due to MARSI (medical adhesive related skin injury) can occur in stoma care. Skin-stripping (removing or tearing the epidermis with the removal of the adhesive faceplate) is a particularly prevalent form of Peristomal MARSI. It is vital to use adhesive removal products and advanced skin protective barrier products. 

Best Practice steps to protect skin in stoma patients 

Adhesive Removal product Lifteez helps prevent skin stripping from PMARSI. And Medi Derma-S Total Barrier Film, a silicone-based, long-lasting, non-sting formulation forms a protective uniform film when evenly applied to the skin. Its barrier properties protect damaged and intact skin from the harmful effects of moisture, irritants and from potential skin damage that may be caused from the application of adhesive stoma pouches.  

Peristomal skincare – is it time to do better for our patients? Understanding the scale of the problem 

Reference: The S.M.A.R.T. Resource is the property of Medicareplus International and supports the implementation of recommendations in the NICE guidelines on: Pressure Ulcers: Prevention and Management (CG179), Urinary Incontinence and Pelvic Floor Organ Prolapse in Women: Management (NG123), Faecal Incontinence in Adults: Management (CG39), December 2019.